LL-37

Specifications

INN

Ropocamptide

IUPAC / systematic name

H-Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser-OH

Chemical class

Cathelicidin-Derived Peptide

CAS registry

154947-66-7 · PubChem

Molecular weight

4,493.4 g/mol

Amino acids

37

Form

Lyophilized powder

Structure note

Linear amphipathic helix; no cysteine, no disulfide bridges

Quality documentation

Passing reports on record for each compound-size lot, counted once per laboratory. Purity is the lowest reported passing figure. Each batch has its own testing target; meeting it is one requirement for release.

5mg

lot EP-A1069 · purity 99.11% · 3 passing reports on record · Batch target: 3

Intended use

For in-vitro laboratory research by qualified professionals. Not for human or veterinary use of any kind — not a drug, food, cosmetic or supplement. The buyer is responsible for lawful handling, storage and disposal.

Researchers should consult the primary scientific literature for published experimental protocols and conditions relevant to their specific in-vitro or laboratory applications.